Rajeev M. Shah, Director at Cytek Biosciences, Inc. (CTKB), bought 1,269,276 shares at $12.95 ($16.3M) on 2022-03-10, disclosed to the SEC on 2022-03-11.
Open-market purchase of $16.3M CTKB by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.99 | 40,154 | $522K | 3.2% |
| 2 | $12.99 | 40,154 | $522K | 3.2% |
| 3 | $12.95 | 256,992 | $3.3M | 20.4% |
| 4 | $12.95 | 256,992 | $3.3M | 20.4% |
| 5 | $12.77 | 337,492 | $4.3M | 26.4% |
| 6 | $12.77 | 337,492 |
| $4.3M |
| 26.4% |
| Total | $12.86 avg | 1,269,276 | $16.3M | 100% |
| Filing → |
| SEPN | BUY | 2024-10-30 | $75.1M | — | Filing → |
| AVTE | BUY | 2024-06-20 | $3.1M | — | Filing → |
| HOWL | BUY | 2023-01-10 | $4.1M | — | Filing → |